Project AITS - AIDS/TB Saar

Tuberculosis and HIV/AIDS are on the rise worldwide, representing a global public health problem with considerable mutual interaction: TB is the leading cause of death of people suffering from HIV/AIDS, and HIV is the most potent force driving the TB epidemic in countries with a high prevalence of HIV.

Although TB caused by Mycobacterium tuberculosis is in general curable, early stopped treatment can result in new dangerous forms of TB: Multi-drug-resistant tuberculosis (MDR-TB) and  extensively drug-resistant tuberculosis (XDR-TB).

These new pathogens spread rapidly from Eastern-Europe – today, Germany has already the highest occurrence of MDR-TB among all Western-Europe countries.

Against this background, Saarland has taken many efforts during the last years to combine its expertise and to attract funding (EU, WHO, BMBF) to set up a competence centre, dedicated to profound knowledge on HIV and TB.

The initiative AITS-AIDS/TB Saar will develop custom-made strategic concepts to strengthen the cooperation between researchers and enterprises in Saarland and support collaboration between regional, national and international partners.

AITS will boost the development of regional technologies and support the dissemination and exploitation of results on European and international level to promote Saarland as an economic global player in the field of AIDS/TB-research.